Acute Femoral Artery Occlusion and Lower Extremity Ischemia in a Patient with COVID-19: A Case Report

Abstract

Clinical spectrum of COVID-19 disease; it ranges from asymptomatic infection to severe disease with hypoxaemic respiratory failure, septic shock and multi-organ dysfunction requiring invasive mechanical ventilation and other organ support in intensive care units. The presence of hypercoagulation, which is characterized by micro and macro vascular thrombotic angiopathy, has been shown to serious and critical conditions in COVID-19 patients. In this case; lower extremity ischemia due to acute femoral artery occlusion during follow-up in the intensive care unit due to severe COVID-19 disease is presented.

Keywords

• Arterial occlusion
• Lower limb ischemia
• COVID-19
• SARS-COV-2

COVID-19 Hastasında Gelişen Akut Femoral Arter Tıkanıklığı ve Alt Ekstremite İskemisi: Olgu Sunumu

Öz

COVID-19 hastalığının klinik spektrumu; asemptomatik enfeksiyondan yoğun bakım ünitelerinde invazif mekanik ventilasyon ve diğer organ desteği gerektiren hipoksemik solunum yetmezliği, septik şok ve çoklu organ disfonksiyonu ile seyreden şiddetli hastalığa kadar uzanır. COVID-19 hastalarında gelişen ciddi ve kritik tablolara mikro ve makro vasküler trombotik anjiyopati ile karakterize olan hiperkoagülasyon durumunun varlığı gösterilmiştir. Bu olguda; ağır seyirli COVID-19 hastalığından dolayı yoğun bakım ünitesinde takip edilen, takibi sırasında akut femoral arter tıkanıklığı sonucunda gelişen alt ekstremite iskemisi sunulmuştur.

Anahtar Kelimeler

• Arteryel tıkanıklık
• Alt ekstremite iskemisi
• COVID-19
• SARS-CoV-2

Kaynakça

1. 1. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int. Erişim: 04.11.2020
2. 2. Hassan SA, Sheikh FN, Jamal S, et al. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus 2020;12.
3. 3. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417 – 1418.
4. 4. Henry BM, Vikse J, Benoit S, et al. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clinica Chim Acta 2020; 507: 167e73.
5. 5. Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure. Thromb Haemost 2020; 120: 998e1000.
6. 6. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020; 46: 1089e98.
7. 7. Cheruiyot I, Kipkorir V, Ngure B, Misiani M, Munguti J, Ogeng'o J. Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review [published online ahead of print, 2020 Aug 28]. Ann Vasc Surg. 2020; S0890-5096(20)30767-6. doi:10.1016/j.avsg.2020.08.087
8. 8. Zhao M, Wang M, Zhang J, Ye J, Xu Y, Wang Z, Ye D, Liu J, Wan J. Advances in the relationship between coronavirus infection and cardiovascular diseases. Biomed Pharmacother. 2020 Jul; 127: 110230. doi: 10.1016/j.biopha.2020.110230. Epub 2020 May 13. PMID: 32428835; PMCID: PMC7218375.

9. 9. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endo- theliitis in COVID-19. Lancet 2020; 395: 1417-8.
10. 10. Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: incidence, patho- physiology, and management. Thromb Res 2020; 194: 101-15.
11. 11. Goldman IA, Ye K, Scheinfeld MH. Lower-extremity Arterial Thrombosis Associated with COVID-19 Is Characterized by Greater Thrombus Burden and Increased Rate of Amputation and Death. Radiology. 2020; 297(2): E263-E269. doi:10.1148/radiol.2020202348